Market Overview:
The global iris ophthalmic drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising awareness about eye health, and technological advancements in ophthalmic devices. The global iris ophthalmic drugs market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into dilation drugs, anti-infective drugs, and other drugs. Dilation drugs are further sub-segmented into mydriatics and cycloplegics. Anti-infective agents are further sub-segmented into antibiotics and antivirals/antifungals. Other types include corticosteroids and prostaglandins analogs (PGAs). On the basis of application, the market is segmented into hospital pharmacies, clinic pharmacies,, retail pharmacies,, household users,,and others including veterinary clinics,. The hospital pharmacy segment accounted for a major share ofthe global iris ophthalmic drugmarket in 2017 owing tothe high incidenceofeye diseasesin hospitals as comparedto otherapplication segments.On themarket byregion,.However,.
Product Definition:
Iritis ophthalmic drugs are medications that are used to treat iritis, a condition that is characterized by inflammation of the iris. Iritis ophthalmic drugs may be used to reduce inflammation, pain, and other symptoms associated with the condition.
Dilation Drugs:
Dilation drugs are used for the treatment of glaucoma and cataract. The drug increases the size of a person's pupil, which allows more space in the eye for ocular fluid to flow through, thus reducing pressure inside the eye. This is done by decreasing or eliminating resistance within the eye muscles.
Anti-infective Drugs:
Anti-infective drugs are used to treat bacterial, fungal or viral infections. Anti-infective drugs can be used individually or in combination with other medicines. Some of the anti-infective agents include cephalosporin, aminoglycosides, tetracycline antibiotics and sulfonamides.
Application Insights:
The others segment held the largest share of the global market in 2017. This is due to a high prevalence of eye diseases such as glaucoma, diabetic retinopathy and ocular hypertension among other disorders. The household application segment is expected to witness lucrative growth over the forecast period owing to rising awareness about early diagnosis and treatment options for various eye diseases at home with minimal or no hospitalization required.
Iritis is one of the most common reasons for visits to an Ophthalmologist (OP). According to data published by Eye Bank Association Of America (EBA), in 2015, more than 685 thousand people throughout U.S., had some form of eye disease which resulted in nearly 47 thousand corneal transplants being performed that year alone.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the local presence of major players, high adoption of advanced treatment procedures and a large patient pool suffering from this condition. In addition, favorable reimbursement policies for iris diseases are also expected to drive growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing disposable income levels and rising healthcare expenditure in emerging countries such as China and India.
Major players operating in this industry include Bausch & Lomb Inc.; Cipla Inc.; Dr Reddy's Laboratories Ltd; Ifft International Holdings Pvt Ltd; Merck KGaA; Novartis AG; Pfizer Inc.
Growth Factors:
- Increasing incidence of iritis
- Growing awareness about iritis and its treatment options
- Rising demand for ophthalmic drugs to treat iritis
- Technological advancements in the field of ophthalmology
- Growing number of clinical studies on new drugs for the treatment of iritis
Scope Of The Report
Report Attributes
Report Details
Report Title
Iritis Ophthalmic Drugs Market Research Report
By Type
Dilation Drugs, Anti-infective Drugs, Other
By Application
Hospital, Clinic, Household, Others
By Companies
Novartis, Allergan, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Senju Pharmaceutical, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
217
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Iritis Ophthalmic Drugs Market Report Segments:
The global Iritis Ophthalmic Drugs market is segmented on the basis of:
Types
Dilation Drugs, Anti-infective Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Allergan
- Bausch Health
- Santen Pharmaceutical
- Lupin Pharmaceuticals
- Apotex
- Akorn
- Senju Pharmaceutical
- Novartis
Highlights of The Iritis Ophthalmic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dilation Drugs
- Anti-infective Drugs
- Other
- By Application:
- Hospital
- Clinic
- Household
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Iritis Ophthalmic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Iritis is an inflammation of the eye. Iritis drugs are medications used to treat this condition. These drugs can help improve vision by relieving the pain and swelling caused by iritis.
Some of the major companies in the iritis ophthalmic drugs market are Novartis, Allergan, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Senju Pharmaceutical, Novartis.
The iritis ophthalmic drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Iritis Ophthalmic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Iritis Ophthalmic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Iritis Ophthalmic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Iritis Ophthalmic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Iritis Ophthalmic Drugs Market Size & Forecast, 2018-2028
4.5.1 Iritis Ophthalmic Drugs Market Size and Y-o-Y Growth
4.5.2 Iritis Ophthalmic Drugs Market Absolute $ Opportunity
Chapter 5 Global Iritis Ophthalmic Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Iritis Ophthalmic Drugs Market Size Forecast by Type
5.2.1 Dilation Drugs
5.2.2 Anti-infective Drugs
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Iritis Ophthalmic Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Iritis Ophthalmic Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Household
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Iritis Ophthalmic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Iritis Ophthalmic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Iritis Ophthalmic Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Iritis Ophthalmic Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Iritis Ophthalmic Drugs Market Size Forecast by Type
9.6.1 Dilation Drugs
9.6.2 Anti-infective Drugs
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Iritis Ophthalmic Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Household
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Iritis Ophthalmic Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Iritis Ophthalmic Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Iritis Ophthalmic Drugs Market Size Forecast by Type
10.6.1 Dilation Drugs
10.6.2 Anti-infective Drugs
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Iritis Ophthalmic Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Household
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Iritis Ophthalmic Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Iritis Ophthalmic Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Iritis Ophthalmic Drugs Market Size Forecast by Type
11.6.1 Dilation Drugs
11.6.2 Anti-infective Drugs
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Iritis Ophthalmic Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Household
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Iritis Ophthalmic Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Iritis Ophthalmic Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Iritis Ophthalmic Drugs Market Size Forecast by Type
12.6.1 Dilation Drugs
12.6.2 Anti-infective Drugs
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Iritis Ophthalmic Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Household
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Iritis Ophthalmic Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Iritis Ophthalmic Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Iritis Ophthalmic Drugs Market Size Forecast by Type
13.6.1 Dilation Drugs
13.6.2 Anti-infective Drugs
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Iritis Ophthalmic Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Household
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Iritis Ophthalmic Drugs Market: Competitive Dashboard
14.2 Global Iritis Ophthalmic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Allergan
14.3.3 Bausch Health
14.3.4 Santen Pharmaceutical
14.3.5 Lupin Pharmaceuticals
14.3.6 Apotex
14.3.7 Akorn
14.3.8 Senju Pharmaceutical
14.3.9 Novartis
